Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $16.2 million.

  • Alignment Healthcare's Share-based Compensation fell 597.4% to $16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.2 million, marking a year-over-year decrease of 757.64%. This contributed to the annual value of $71.1 million for FY2024, which is 642.93% up from last year.
  • According to the latest figures from Q3 2025, Alignment Healthcare's Share-based Compensation is $16.2 million, which was down 597.4% from $15.6 million recorded in Q2 2025.
  • Over the past 5 years, Alignment Healthcare's Share-based Compensation peaked at $30.9 million during Q2 2021, and registered a low of $12.1 million during Q2 2022.
  • In the last 5 years, Alignment Healthcare's Share-based Compensation had a median value of $17.3 million in 2024 and averaged $20.0 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 993651.32% in 2021, then crashed by 6082.82% in 2022.
  • Quarter analysis of 5 years shows Alignment Healthcare's Share-based Compensation stood at $28.8 million in 2021, then fell by 20.58% to $22.9 million in 2022, then plummeted by 31.61% to $15.7 million in 2023, then increased by 3.73% to $16.2 million in 2024, then decreased by 0.06% to $16.2 million in 2025.
  • Its Share-based Compensation was $16.2 million in Q3 2025, compared to $15.6 million in Q2 2025 and $17.2 million in Q1 2025.